LAUREN BOLEY: Open Payments
NPI 1134677362 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 73 payments from 10 companies in 2025. Trend: 2023 $606 · 2024 $1,198 · 2025 $2,122
Food & beverage: $2,013Education: $108
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 20 | $515 |
| Janssen Biotech, Inc. | 16 | $481 |
| ABBVIE INC. | 22 | $370 |
| Gilead Sciences, Inc. | 6 | $351 |
| Phathom Pharmaceuticals, Inc. | 2 | $152 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| GENZYME CORPORATION | 1 | $30 |
| EVOKE PHARMA, INC. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: IBSRELA, TREMFYA, SKYRIZI, VOQUEZNA, REZDIFFRA, LINZESS, RINVOQ, ENTYVIO.
Industry payments across LA — which companies pay providers there.
